Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$0.50
+2.7%		$0.61
$0.43
▼
$2.04
$9.33M-2.71106,772 shs55,656 shs
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$1.20
-3.2%		$1.16
$1.00
▼
$5.50
$14.13M1.65163,541 shs176,119 shs
iSpecimen Inc. stock logo
ISPC
iSpecimen
$1.54
$2.12
$1.40
▼
$127.20
$3.88M1.62537,398 shs4.11 million shs
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
$0.28
-0.3%		$0.50
$0.26
▼
$5.30
$4.61M1.456.19 million shs254,237 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.00%-6.83%-14.86%-25.01%-58.07%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.00%+2.56%+9.09%+2.56%-69.07%
iSpecimen Inc. stock logo
ISPC
iSpecimen
0.00%0.00%-30.00%-49.01%-94.27%
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
0.00%-2.49%-15.67%-76.82%-88.96%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$0.50
+2.7%		$0.61
$0.43
▼
$2.04
$9.33M-2.71106,772 shs55,656 shs
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$1.20
-3.2%		$1.16
$1.00
▼
$5.50
$14.13M1.65163,541 shs176,119 shs
iSpecimen Inc. stock logo
ISPC
iSpecimen
$1.54
$2.12
$1.40
▼
$127.20
$3.88M1.62537,398 shs4.11 million shs
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
$0.28
-0.3%		$0.50
$0.26
▼
$5.30
$4.61M1.456.19 million shs254,237 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.00%-6.83%-14.86%-25.01%-58.07%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.00%+2.56%+9.09%+2.56%-69.07%
iSpecimen Inc. stock logo
ISPC
iSpecimen
0.00%0.00%-30.00%-49.01%-94.27%
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
0.00%-2.49%-15.67%-76.82%-88.96%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
1.50
ReduceN/AN/A
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
2.00
Hold$6.00400.00% Upside
iSpecimen Inc. stock logo
ISPC
iSpecimen
1.00
SellN/AN/A
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BFRG, BNGO, VIVS, and ISPC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
8/19/2026
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/18/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (E+) ➝ Sell (E)
8/3/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/29/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
iSpecimen Inc. stock logo
ISPC
iSpecimen
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/26/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$120K77.74N/AN/A$0.38 per share1.32
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$28.51M0.50N/AN/A$2.68 per share0.45
iSpecimen Inc. stock logo
ISPC
iSpecimen
$466.30K8.32N/AN/A$0.69 per share2.23
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
$130K35.50N/AN/A($0.14) per share-1.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$6.50M-$0.46N/AN/AN/AN/A-150.36%-127.98%11/13/2026 (Estimated)
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$26.40M-$3.02N/AN/AN/A-106.58%-78.78%-48.54%10/29/2026 (Estimated)
iSpecimen Inc. stock logo
ISPC
iSpecimen
-$10.49M-$56.44N/AN/AN/A-2,445.40%-524.39%-140.42%11/5/2026 (Estimated)
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
-$13.84M-$4.47N/AN/AN/A-11,016.07%-612.23%-177.02%N/A

Latest BFRG, BNGO, VIVS, and ISPC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$0.11-$0.07+$0.04-$0.07$0.22 million$0.22 million
8/14/2026Q2 2026
iSpecimen Inc. stock logo
ISPC
iSpecimen
N/A-$0.98N/A-$0.98N/A$0.15 million
8/12/2026Q1 2027
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
N/A-$0.25N/A-$0.25N/A$0.02 million
8/10/2026Q2 2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$0.67-$0.64+$0.03-$0.64$7.55 million($6.67) million
7/14/2026Q4 2026
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
N/A-$2.21N/A-$2.21N/A$0.04 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/AN/AN/AN/AN/A
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
N/AN/AN/AN/AN/A
iSpecimen Inc. stock logo
ISPC
iSpecimen
N/AN/AN/AN/AN/A
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/A
10.57
10.57
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.11
2.48
1.96
iSpecimen Inc. stock logo
ISPC
iSpecimen
N/A
0.82
0.82
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
N/A
1.70
1.70

Institutional Ownership

CompanyInstitutional Ownership
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.96%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
11.35%
iSpecimen Inc. stock logo
ISPC
iSpecimen
13.62%
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
8.23%

Insider Ownership

CompanyInsider Ownership
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
14.70%
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.65%
iSpecimen Inc. stock logo
ISPC
iSpecimen
12.20%
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
418.54 million15.82 millionNot Optionable
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
30011.78 million11.70 millionNo Data
iSpecimen Inc. stock logo
ISPC
iSpecimen
602.52 million2.21 millionNot Optionable
VivoSim Labs, Inc. stock logo
VIVS
VivoSim Labs
2016.59 million16.42 millionN/A

Recent News About These Companies

VivoSim Labs (NASDAQ:VIVS) Trading Down 0.3% - Should You Sell?
September 4 at 2:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31001934
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
September 1, 2026  |  financialpost.comF
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
September 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354127/37000/en/vivosim-labs-to-add-rat-liver-model-to-namkind-platform.html
VivoSim Provides Financial and Listing Compliance Update
August 6, 2026  |  financialpost.comF
VivoSim Provides Financial and Listing Compliance Update
August 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3340246/37000/en/vivosim-provides-financial-and-listing-compliance-update.html
VivoSim Labs Sets 2026 Annual Shareholder Meeting Date
July 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vivosim-labs-sets-2026-annual-shareholder-meeting-date?utm_source=marketbeat.com&utm_medium=referral
VivoSim Labs, Inc. (VIVS)
July 28, 2026  |  ca.finance.yahoo.comhttps://ca.finance.yahoo.com/quote/VIVS/press-releases/
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
July 21, 2026  |  financialpost.comF
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
July 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/21/3330426/37000/en/vivosim-enters-china-with-first-commercial-sales-of-namkind-toxicology-screening-and-efficacy-testing-services.html
VivoSim Labs Earnings Estimates, EPS & Revenue | NASDAQ:VIVS
July 16, 2026  |  benzinga.comhttps://www.benzinga.com/quote/VIVS/earnings
Why Vivosim Labs Shares Are Rocketing on Wednesday?
July 16, 2026  |  msn.comhttps://www.msn.com/en-us/money/news/why-vivosim-labs-shares-are-rocketing-on-wednesday/ar-AA27YpW0
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor
July 16, 2026  |  financialpost.comF
VivoSim Labs Announces $4.0 Million Private Placement with Institutional Investor and Warrant Amendment
July 16, 2026  |  quiverquant.comQ
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor
July 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/16/3328441/37000/en/vivosim-announces-pricing-of-4-0-million-private-placement-priced-at-the-market-under-nasdaq-rules-with-a-single-healthcare-focused-institutional-investor.html
Three Biotechs Deliver Catalysts to Watch
July 15, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/three-biotechs-deliver-catalysts-to-watch-1036328350
VivoSim Labs Announces $5 Million Lilly Milestone Payment and FY2027 Revenue Growth Guidance
July 15, 2026  |  quiverquant.comQ
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
July 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/15/3327689/37000/en/vivosim-receives-5m-milestone-payment-from-eli-lilly-provides-guidance-that-it-expects-revenue-growth-of-500-in-fy2027.html
VivoSim: Fiscal Q4 Earnings Snapshot
July 14, 2026  |  stamfordadvocate.comS
VivoSim Labs Delays Annual SEC Filing
June 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vivosim-labs-delays-annual-sec-filing?utm_source=marketbeat.com&utm_medium=referral
VivoSim Skids on Data
June 29, 2026  |  baystreet.cahttps://www.baystreet.ca/stockstowatch/23570/VivoSim-Skids-on-Data

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bullfrog AI stock logo

Bullfrog AI NASDAQ:BFRG

$0.50 +0.01 (+2.69%)
As of 09/4/2026 04:00 PM Eastern

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Bionano Genomics stock logo

Bionano Genomics NASDAQ:BNGO

$1.20 -0.04 (-3.23%)
As of 09/4/2026 04:00 PM Eastern

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

iSpecimen stock logo

iSpecimen NASDAQ:ISPC

$1.54 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

VivoSim Labs stock logo

VivoSim Labs NASDAQ:VIVS

$0.28 0.00 (-0.29%)
As of 09/4/2026 04:00 PM Eastern

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas